A Phase 2a Study to Investigate REM0046127 in Mild to Moderate Alzheimer's Disease

Clinical trial NCT05478031 · TERMINATED

Trial details

NCT number: NCT05478031
Sponsor: reMYND
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Alzheimer Disease

Start date: 2022-06-07
Primary completion: 2024-06-04
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.